[1]
L. G. Farfán-Chávez and K. A. Pérez-Acuña Medina, “Modified antituberculosis regimen due to hepatotoxicity caused by Pyrazinamide: Case report”, Rev. Cuerpo Med. HNAAA, vol. 16, no. 1, pp. 134–137, Jun. 2023.